Cassava Sciences Inc (SAVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,617 | -15,925 | -14,337 | -17,480 | -4,500 |
| Depreciation Amortization | 341 | 349 | 245 | 45 | 4 |
| Accounts payable and accrued liabilities | 960 | -899 | -143 | 2,012 | 193 |
| Other Working Capital | 630 | -196 | 144 | 1,287 | 174 |
| Other Operating Activity | -848 | 1,173 | 1,390 | 6,750 | 1,464 |
| Operating Cash Flow | $-20,534 | $-15,498 | $-12,701 | $-7,386 | $-2,664 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -65,270 | N/A | 329 | N/A | N/A |
| PPE Investments | -26 | -7 | -1,342 | -1,302 | -39 |
| Investing Cash Flow | $-65,296 | $-7 | $-1,013 | $-1,302 | $-39 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 47,644 | 263 | 61 | 63,030 | 0 |
| Other Financing Activity | 122 | 59 | 0 | 15,245 | 9,709 |
| Financing Cash Flow | $47,766 | $322 | $61 | $78,275 | $9,709 |
| Beginning Cash Position | 50,091 | 65,274 | 78,927 | 9,340 | 2,334 |
| End Cash Position | 12,027 | 50,091 | 65,274 | 78,927 | 9,340 |
| Net Cash Flow | $-38,064 | $-15,183 | $-13,653 | $69,587 | $7,006 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,534 | -15,498 | -12,701 | -7,386 | -2,664 |
| Capital Expenditure | -26 | -7 | -1,342 | -1,302 | -39 |
| Free Cash Flow | -20,560 | -15,505 | -14,043 | -8,688 | -2,703 |